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Anti-malarial and anti-inflammatory effects of Gleichenia truncata mediated 
through inhibition of GSK3ß 
Abstract 
Gleichenia truncata is a highland fern from the Gleicheniaceae family known for 
its traditional use among indigenous communities in Asia to treat fever. The 
scientific basis of its effect has yet to be documented. A yeast-based kinase 
assay conducted in our laboratory revealed that crude methanolic extract (CME) 
of G. truncata exhibited glycogen synthase kinase-3 (GSK3)-inhibitory activity. 
GSK3β is now recognized to have a pivotal role in the regulation of inflammatory 
response during bacterial infections. We have also previously shown that lithium 
chloride (LiCl), a GSK3 inhibitor suppressed development of Plasmodium berghei 
in a murine model of malarial infection. The present study is aimed at evaluating 
G. truncata for its anti-malarial and anti-inflammatory effects using in vivo 
malarial and melioidosis infection models respectively. In a four-day suppressive 
test, intraperitoneal injections of up to 250 mg/kg body weight (bw) G. truncata 
CME into P.berghei-infected mice suppressed parasitaemia development by 
>60%. Intraperitoneal administration of 150 mg/kg bw G. truncata CME into 
Burkholderia pseudomallei-infected mice improved survivability by 44%. G. 
truncata CME lowered levels of pro-inflammatory cytokines (TNF-α, IFN-γ) in 
serum and organs of B. pseudomallei-infected mice. In both infections, increased 
phosphorylations (Ser9) of GSK3β were detected in organ samples of animals 
administered with G. truncata CME compared to controls. Taken together, results 
from this study strongly suggest that the anti-malarial and anti-inflammatory 
effects elicited by G. truncata in part were mediated through inhibition of GSK3β. 
The findings provide scientific basis for the ethnomedicinal use of this fern to 
treat inflammation-associated symptoms. 
